Latest News
Calibrate Partners, the London-based hedge fund founded by former Morgan Stanley executive John White, has opened an office in Dubai as part of its international expansion, according to a report by Financial News London citing people familiar with the matter.
Trading Technologies has acquired OpenGamma, a specialist in derivatives margin analytics, in a move that strengthens TT’s multi-asset platform and expands its offering in margin optimisation and capital efficiency for institutional trading firms.
Eric Jackson, the activist hedge fund investor known for his contrarian bets, is launching a digital-asset treasury company – EMJ Crypto Technologies – just as the corporate crypto-holding model faces a downturn, according to a report by Bloomberg.
The global non-bank financial sector, commonly known as “shadow banking,” has expanded at double the pace of traditional lenders, according to a report by Bloomberg citing research by the Financial Stability Board.
Citadel, the hedge fund and financial conglomerate founded by Ken Griffin, is relocating its remaining Chicago staff from the iconic Citadel Center in the Loop to a smaller office north of the Chicago River, according to a report by Bloomberg citing unnamed sources familiar with the matter.
Broadridge Financial Solutions has rolled out a series of upgrades to its multi-asset portfolio and trade order management platform, strengthening its appeal to hedge funds and alternative investment managers seeking more unified front-to-back technology.
Edinburgh Worldwide Investment Trust has called on shareholders to reject proposals from activist investor Saba Capital to replace members of its board, arguing that the trust has made progress and the change would create uncertainty, according to a report by CNBC.
Citadel founder Ken Griffin has warned that elements of the Republican policy agenda, including tougher immigration controls and tariffs, are contributing to inflationary pressures in the US, even as deregulation could ultimately help bring prices down, according to a report by Bloomberg.
Several biopharma-focused hedge fund firms have taken positions in a merger involving a special purpose acquisition company sponsored by life sciences investor Perceptive Advisors, according to a report by Institutional Investor.